Novo Nordisk's Cagri-Sema Evergreening The Franchise Part I Novo Nordisk, the leader in weight loss market, is going after tolerability instead of efficacy with this combination drug targeting GLP-1 and amylin
A Helimeds-affiliated provider will review your answers and get back to you
In a study of Wegovy in people with or without type 2 diabetes, people taking 1.7 mg and 2.4 mg dosages lost an average of 2% of their body weight after one month
Supporting overall wellness while taking GLP-1 medications can include lifestyle changes and nutritional support
GLP-1 therapy can help address the biological shifts that make weight management feel so challenging during this transition, and combining this medical support with thoughtful lifestyle adjustments can make all the difference
CAREolina Wellness and Infusion Center 1332 Westgate Center Drive Winston-Salem, NC 27103 Phone: (336) 999-7116 Website: Book Online: Schedule a consultation to compare GLP-1 medication and peptide therapy options for your goals, review safety and costs, and leave with a clear, sustainable plan.